UK Markets close in 3 hrs 17 mins

Zealand Pharma A/S (ZEAL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
32.28-0.18 (-0.57%)
At close: 11:19AM EDT
32.11 -0.17 (-0.51%)
Pre-market: 07:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close32.46
Open32.07
Bid32.08 x 1000
Ask32.19 x 1100
Day's range32.03 - 32.42
52-week range24.97 - 40.00
Volume5,524
Avg. volume21,950
Market cap1.457B
Beta (5Y monthly)0.85
PE ratio (TTM)N/A
EPS (TTM)-3.66
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est37.81
  • Globe Newswire

    Total number of shares and voting rights in Zealand Pharma at September 30, 2021

    Company announcement – No. 62 / 2021 Total number of shares and voting rights in Zealand Pharma at September 30, 2021 Copenhagen, DK and Boston, MA, September 30, 2021 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at

  • Globe Newswire

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

    Company announcement – No. 61 / 2021 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, DK and Boston, MA, U.S., September 10, 2021 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, has received information on transactions in Zealand's shares

  • Globe Newswire

    Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

    Company announcement – No. 60 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S. September 10, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 30,748 divided into 30,748 new shares with a nominal value of DKK 1 each. The